Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Pharmacy and Pharmacology|September 1, 1990
Leukotriene receptor antagonism and augmentation of beta-receptor-mediated events by LY171883L E Rinkema, C R Roman, W L Russell, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritisA M Bendele, D N Benslay, J T Hom, et al.
European Journal of Pharmacology|November 23, 1992
Pulmonary actions of LY255283, a leukotriene B4 receptor antagonistS A Silbaugh, P W Stengel, S L Cockerham, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 14, 2000
Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studiesS A Silbaugh, P W Stengel, S L Cockerham, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1993
Bronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pigP W Stengel, R D Dillard, H L Cho, et al.
Biochemical Pharmacology|April 4, 1997
The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111)J P van Pelt, E M de Jong, P E van Erp, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitorJ H Fleisch, C T Armstrong, C R Roman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studiesW T Jackson, L L Froelich, R J Boyd, et al.
Pageof 4